Holy Cross 9th Annual Winter Oncology Symposium

https://www.hconcologysymposium.com/

 

Holy Cross 9th Annual Winter Oncology Symposium
Avatar

Pneumonitis, Thyroiditis, Myocarditis, and Hepatitis as Side Effects in IO Treatment of NSCLC

By Holy Cross 9th Annual Winter Oncology Symposium FEATURING Ibiayi Dagogo-Jack
By Holy Cross 9th Annual Winter Oncology Symposium FEATURING Ibiayi Dagogo-Jack
0 views
May 15, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin
Lung Cancers
23:25
Holy Cross 9th Annual Winter Oncology Symposium

The Use of EBUS in Early Detection of Lung Cancers

Feat. S. Kosseifi
16:59
Holy Cross 9th Annual Winter Oncology Symposium

PD-L1 Monotherapy vs. PD-L1+Chemo Combination Therapy in Metastatic …

Feat. I. Dagogo-Jack
15:56
Holy Cross 9th Annual Winter Oncology Symposium

Pneumonitis, Thyroiditis, Myocarditis, and Hepatitis as Side Effects…

Feat. I. Dagogo-Jack
05:39
Holy Cross 9th Annual Winter Oncology Symposium

Re-Challenging with Immunotherapy in Metastatic NSCLC: Would Retreat…

Feat. I. Dagogo-Jack
23:13
Holy Cross 9th Annual Winter Oncology Symposium

Targeted Therapy and Related Side Effects in Advanced NSCLC

Feat. L. Raez
15:04
Holy Cross 9th Annual Winter Oncology Symposium

Genomic Profiling for Metastatic NSCLC

Feat. D. Drew
17:27
Holy Cross 9th Annual Winter Oncology Symposium

Stereotactic Radiotherapy in Stage I Lung Cancer

Feat. L. Goyal, V. Patel